€111.65
1.18% today
Xetra, Jun 26, 03:12 pm CET
ISIN
DE0006599905
Symbol
MRK
Index
Sector
Industry

Merck Stock price

€110.35
-5.25 4.54% 1M
-27.50 19.95% 6M
-29.55 21.12% YTD
-47.15 29.94% 1Y
-54.75 33.16% 3Y
+7.60 7.40% 5Y
+16.50 17.58% 10Y
+78.35 244.84% 20Y
Xetra, Closing price Wed, Jun 25 2025
-1.35 1.21%
ISIN
DE0006599905
Symbol
MRK
Index
Sector
Industry

Key metrics

Basic
Market capitalization
€48.6b
Enterprise Value
€55.6b
Net debt
€7.1b
Cash
€1.6b
Shares outstanding
434.8m
Valuation (TTM | estimate)
P/E
17.03 | 15.75
P/S
2.28 | 2.25
EV/Sales
2.61 | 2.57
EV/FCF
25.64
P/B
1.61
Dividends
DPS
€2.20
Yield 1Y | 5Y
1.99% | 1.26%
Growth 1Y | 5Y
0.00% | 11.10%
Payout 1Y | 3Y
34.43% | 32.13%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€21.3b | €21.6b
EBITDA
€5.9b | €6.1b
EBIT
€3.7b
Net Income
€2.8b | €3.0b
Free Cash Flow
€2.2b
Growth (TTM | estimate)
Revenue
2.38% | 2.17%
EBITDA
8.32% | 23.91%
EBIT
4.98%
Net Income
3.45% | 9.68%
Free Cash Flow
19.03%
Margin (TTM | estimate)
Gross
59.21%
EBITDA
27.59% | 28.27%
EBIT
17.49%
Net
13.22% | 14.09%
Free Cash Flow
10.18%
Financial Health
Equity Ratio
58.01%
Return on Equity
9.28%
ROCE
9.35%
ROIC
7.72%
Debt/Equity
0.29
More
EPS
€6.48
FCF per Share
€4.99
Short interest
-
Employees
59.02k
Rev per Employee
€360.00k
Show more

Create a Free Account to create an Merck alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Merck Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Merck forecast:

15x Buy
83%
2x Hold
11%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a Merck forecast:

Buy
83%
Hold
11%
Sell
6%

Financial data from Merck

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
21,316 21,316
2% 2%
100%
- Direct Costs 8,695 8,695
1% 1%
41%
12,621 12,621
4% 4%
59%
- Selling and Administrative Expenses 5,954 5,954
2% 2%
28%
- Research and Development Expense 2,249 2,249
7% 7%
11%
5,882 5,882
8% 8%
28%
- Depreciation and Amortization 2,153 2,153
15% 15%
10%
EBIT (Operating Income) EBIT 3,729 3,729
5% 5%
17%
Net Profit 2,817 2,817
3% 3%
13%

In millions EUR.

Don't miss a Thing! We will send you all news about Merck directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Merck Stock News

AD HOC NEWS
30 days ago
Der Technologie- und Pharmakonzern Merck KGaA DE0006599905 will nach erfolgreichen klinischen Tests noch in diesem Jahr die Marktzulassung für sein Tumor-Medikament Pimicotinib bei den Behörden beantragen.
AD HOC NEWS
about one month ago
Das US-Analysehaus Bernstein Research hat das Kursziel für Merck KGaA DE0006599905 von 168 auf 147 Euro gesenkt, aber die Einstufung auf "Market-Perform" belassen.
AD HOC NEWS
about one month ago
Die US-Bank JPMorgan hat das Kursziel für Merck KGaA DE0006599905 von 190 auf 155 Euro gesenkt, aber die Einstufung auf "Overweight" belassen.
More Merck News

Company Profile

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Head office Germany
CEO Belén López
Employees 59,020
Founded 1995
Website www.merckgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today